Piotr Popik - Publications

Affiliations: 
Department of Behavioral Neuroscience & Drug Development Institute of Pharmacology, Polish Academy of Sciences 
Area:
neuroscience, behavioral neuropharmacology, antidepressant pharmacology, rodent behavior, learning and memory, animal models of psychiatric disorders
Website:
http://if-pan.krakow.pl/en/departments/employees/135/Professor-Piotr-Popik-PhD/

182 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Popik P, Cyrano E, Piotrowska D, Holuj M, Golebiowska J, Malikowska-Racia N, Potasiewicz A, Nikiforuk A. Effects of ketamine on rat social behavior as analyzed by DeepLabCut and SimBA deep learning algorithms. Frontiers in Pharmacology. 14: 1329424. PMID 38269275 DOI: 10.3389/fphar.2023.1329424  0.793
2023 Piotrowska D, Potasiewicz A, Popik P, Nikiforuk A. Pro-social and pro-cognitive effects of LIT-001, a novel oxytocin receptor agonist in a neurodevelopmental model of schizophrenia. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 78: 30-42. PMID 37866191 DOI: 10.1016/j.euroneuro.2023.09.005  0.828
2023 Malikowska-Racia N, Koniewski M, Golebiowska J, Popik P. Acute but not long-lasting antidepressant-like effect of psilocybin in differential reinforcement of low-rate 72 schedule in rats. Journal of Psychopharmacology (Oxford, England). 37: 1149-1156. PMID 37842884 DOI: 10.1177/02698811231205692  0.774
2023 Szczepańska K, Bojarski AJ, Popik P, Malikowska-Racia N. Novel object recognition test as an alternative approach to assessing the pharmacological profile of sigma-1 receptor ligands. Pharmacological Reports : Pr. PMID 37572216 DOI: 10.1007/s43440-023-00516-x  0.76
2023 Gzieło K, Piotrowska D, Litwa E, Popik P, Nikiforuk A. Maternal immune activation affects socio-communicative behavior in adult rats. Scientific Reports. 13: 1918. PMID 36732579 DOI: 10.1038/s41598-023-28919-z  0.793
2022 Malikowska-Racia N, Golebiowska J, Nikiforuk A, Khoo SY, Popik P. Effects of ketamine optical isomers, fluoxetine and naloxone on timing in differential reinforcement of low-rate response (DRL) 72-s task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 67: 37-52. PMID 36476352 DOI: 10.1016/j.euroneuro.2022.11.007  0.802
2022 Matloka M, Janowska S, Pankiewicz P, Kokhanovska S, Kos T, Hołuj M, Rutkowska-Wlodarczyk I, Abramski K, Janicka M, Jakubowski P, Świątkiewicz M, Welniak-Kaminska M, Hucz-Kalitowska J, Dera P, Bojarski L, ... ... Popik P, et al. A PDE10A inhibitor CPL500036 is a novel agent modulating striatal function devoid of most neuroleptic side-effects. Frontiers in Pharmacology. 13: 999685. PMID 36438799 DOI: 10.3389/fphar.2022.999685  0.799
2022 Grychowska K, Olejarz-Maciej A, Blicharz K, Pietruś W, Karcz T, Kurczab R, Koczurkiewicz P, Doroz-Płonka A, Latacz G, Keeri AR, Piska K, Satała G, Pęgiel J, Trybała W, Jastrzębska-Więsek M, ... ... Popik P, et al. Overcoming undesirable hERG affinity by incorporating fluorine atoms: A case of MAO-B inhibitors derived from 1 H-pyrrolo-[3,2-c]quinolines. European Journal of Medicinal Chemistry. 236: 114329. PMID 35397400 DOI: 10.1016/j.ejmech.2022.114329  0.75
2022 Popik P, Hogendorf A, Bugno R, Khoo SY, Zajdel P, Malikowska-Racia N, Nikiforuk A, Golebiowska J. Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats. Psychopharmacology. PMID 35234983 DOI: 10.1007/s00213-021-06020-5  0.798
2021 Zajdel P, Grychowska K, Mogilski S, Kurczab R, Satała G, Bugno R, Kos T, Gołębiowska J, Malikowska-Racia N, Nikiforuk A, Chaumont-Dubel S, Bantreil X, Pawłowski M, Martinez J, Subra G, ... ... Popik P, et al. Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT and 5-HT Receptor Antagonist with Antipsychotic and Procognitive Properties. Journal of Medicinal Chemistry. PMID 34467765 DOI: 10.1021/acs.jmedchem.1c00224  0.808
2021 Malikowska-Racia N, Salat K, Gdula-Argasinska J, Popik P. Sex, Pramipexole and Tiagabine Affect Behavioral and Hormonal Response to Traumatic Stress in a Mouse Model of PTSD. Frontiers in Pharmacology. 12: 691598. PMID 34276379 DOI: 10.3389/fphar.2021.691598  0.743
2021 Potasiewicz A, Faron-Gorecka A, Popik P, Nikiforuk A. Repeated treatment with alpha 7 nicotinic acetylcholine receptor ligands enhances cognitive processes and stimulates Erk1/2 and Arc genes in rats. Behavioural Brain Research. 409: 113338. PMID 33940049 DOI: 10.1016/j.bbr.2021.113338  0.816
2021 Gzielo K, Potasiewicz A, Litwa E, Piotrowska D, Popik P, Nikiforuk A. The Effect of Maternal Immune Activation on Social Play-Induced Ultrasonic Vocalization in Rats. Brain Sciences. 11. PMID 33803154 DOI: 10.3390/brainsci11030344  0.798
2021 Drop M, Canale V, Chaumont-Dubel S, Kurczab R, Satała G, Bantreil X, Walczak M, Koczurkiewicz-Adamczyk P, Latacz G, Gwizdak A, Krawczyk M, Gołębiowska J, Grychowska K, Bojarski AJ, Nikiforuk A, ... ... Popik P, et al. 2-Phenyl-1-pyrrole-3-carboxamide as a New Scaffold for Developing 5-HT Receptor Inverse Agonists with Cognition-Enhancing Activity. Acs Chemical Neuroscience. PMID 33705101 DOI: 10.1021/acschemneuro.1c00061  0.649
2021 Shafique H, Witkin JM, Smith JL, Kaniecki K, Sporn J, Holuj M, Krawczyk M, Kuziak A, Popik P. Rapid tolerance to behavioral effects of ethanol in rats: prevention by R-(-)-ketamine. Pharmacology, Biochemistry, and Behavior. 173152. PMID 33577868 DOI: 10.1016/j.pbb.2021.173152  0.758
2020 Haduch A, Pukło R, Alenina N, Nikiforuk A, Popik P, Bader M, Daniel WA. The effect of ageing and cerebral serotonin deficit on the activity of cytochrome P450 2D (CYP2D) in the brain and liver of male rats. Neurochemistry International. 141: 104884. PMID 33091481 DOI: 10.1016/j.neuint.2020.104884  0.593
2020 Gzielo K, Potasiewicz A, Hołuj M, Litwa E, Popik P, Nikiforuk A. Valproic acid exposure impairs ultrasonic communication in infant, adolescent and adult rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. PMID 32978035 DOI: 10.1016/j.euroneuro.2020.09.006  0.789
2020 Canale V, Grychowska K, Kurczab R, Ryng M, Keeri AR, Satała G, Olejarz-Maciej A, Koczurkiewicz P, Drop M, Blicharz K, Piska K, Pękala E, Janiszewska P, Krawczyk M, Walczak M, ... ... Popik P, et al. A dual-acting 5-HT receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties. European Journal of Medicinal Chemistry. 208: 112765. PMID 32949963 DOI: 10.1016/J.Ejmech.2020.112765  0.41
2020 Popik P, Khoo SY, Kuziak A, Golebiowska J, Potasiewicz A, Hogendorf A, Popik O, Matloka M, Moszczynski R, Nikiforuk A, Witkin JM. Distinct cognitive and discriminative stimulus effects of ketamine enantiomers in rats. Pharmacology, Biochemistry, and Behavior. 173011. PMID 32758523 DOI: 10.1016/J.Pbb.2020.173011  0.792
2020 Potasiewicz A, Gzielo K, Popik P, Nikiforuk A. Effects of prenatal exposure to valproic acid or poly(I:C) on ultrasonic vocalizations in rat pups: the role of social cues. Physiology & Behavior. 113113. PMID 32738314 DOI: 10.1016/J.Physbeh.2020.113113  0.792
2020 Caffino L, Verheij MMM, Roversi K, Targa G, Mottarlini F, Popik P, Nikiforuk A, Golebiowska J, Fumagalli F, Homberg JR. Hypersensitivity to amphetamine's psychomotor and reinforcing effects in serotonin transporter knockout rats: glutamate in the nucleus accumbens. British Journal of Pharmacology. PMID 32721055 DOI: 10.1111/Bph.15211  0.305
2020 Nikiforuk A, Litwa E, Krawczyk M, Popik P, Arias H. Correction to: Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats. Pharmacological Reports : Pr. 72: 1078. PMID 32642944 DOI: 10.1007/s43440-020-00128-9  0.643
2020 Witkin JM, Kranzler J, Kaniecki K, Popik P, Smith JL, Hashimoto K, Sporn J. R-(-)-ketamine modifies behavioral effects of morphine predicting efficacy as a novel therapy for opioid use disorder. Pharmacology, Biochemistry, and Behavior. 172927. PMID 32333922 DOI: 10.1016/J.Pbb.2020.172927  0.333
2020 Nikiforuk A, Litwa E, Krawczyk M, Popik P, Arias H. Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats. Pharmacological Reports : Pr. PMID 32207091 DOI: 10.1007/S43440-020-00092-4  0.667
2020 Potasiewicz A, Holuj M, Litwa E, Gzielo K, Socha L, Popik P, Nikiforuk A. Social dysfunction in the neurodevelopmental model of schizophrenia in male and female rats: Behavioural and biochemical studies. Neuropharmacology. 170: 108040. PMID 32165218 DOI: 10.1016/J.Neuropharm.2020.108040  0.812
2020 Potasiewicz A, Krawczyk M, Gzielo K, Popik P, Nikiforuk A. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors enhance procognitive effects of conventional anti-Alzheimer drugs in scopolamine-treated rats. Behavioural Brain Research. 112547. PMID 32087183 DOI: 10.1016/J.Bbr.2020.112547  0.825
2019 Golebiowska J, Hołuj M, Potasiewicz A, Piotrowska D, Kuziak A, Popik P, Homberg JR, Nikiforuk A. Serotonin transporter deficiency alters socioemotional ultrasonic communication in rats. Scientific Reports. 9: 20283. PMID 31889084 DOI: 10.1038/S41598-019-56629-Y  0.803
2019 Kozela E, Krawczyk M, Kos T, Juknat A, Vogel Z, Popik P. Cannabidiol Improves Cognitive Impairment and Reverses Cortical Transcriptional Changes Induced by Ketamine, in Schizophrenia-Like Model in Rats. Molecular Neurobiology. PMID 31823199 DOI: 10.1007/S12035-019-01831-2  0.813
2019 Malikowska-Racia N, Popik P, Sałat K. Behavioral effects of buspirone in a mouse model of posttraumatic stress disorder. Behavioural Brain Research. 112380. PMID 31765726 DOI: 10.1016/j.bbr.2019.112380  0.785
2019 Staroń J, Kurczab R, Warszycki D, Satała G, Krawczyk M, Bugno R, Lenda T, Popik P, Hogendorf AS, Hogendorf A, Dubiel K, Matłoka M, Moszczyński-Pętkowski R, Pieczykolan J, Wieczorek M, et al. Virtual screening-driven discovery of dual 5-HT/5-HT receptor ligands with pro-cognitive properties. European Journal of Medicinal Chemistry. 111857. PMID 31734022 DOI: 10.1016/J.Ejmech.2019.111857  0.36
2019 Popik P, Krawczyk M, Kuziak A, Bugno R, Hogendorf A, Staroń J, Nikiforuk A. Serotonin type 5A receptor antagonists inhibit D-lysergic acid diethylamide discriminatory cue in rats. Journal of Psychopharmacology (Oxford, England). 269881119867603. PMID 31452444 DOI: 10.1177/0269881119867603  0.667
2019 Hogendorf AS, Hogendorf A, Kurczab R, Kalinowska-Tłuścik J, Popik P, Nikiforuk A, Krawczyk M, Satała G, Lenda T, Knutelska J, Bugno R, Staroń J, Pietruś W, Matłoka M, Dubiel K, et al. 2-Aminoimidazole-based antagonists of the 5-HT receptor - A new concept in aminergic GPCR ligand design. European Journal of Medicinal Chemistry. 179: 1-15. PMID 31229883 DOI: 10.1016/J.Ejmech.2019.06.001  0.646
2019 Malikowska-Racia N, Sałat K, Nowaczyk A, Fijałkowski Ł, Popik P. Dopamine D2/D3 receptor agonists attenuate PTSD-like symptoms in mice exposed to single prolonged stress. Neuropharmacology. 155: 1-9. PMID 31085186 DOI: 10.1016/j.neuropharm.2019.05.012  0.765
2019 Grychowska K, Chaumont-Dubel S, Kurczab R, Koczurkiewicz P, Deville C, Krawczyk M, Pietru W, Satała G, Buda S, Piska K, Drop M, Bantreil X, Lamaty F, Pękala E, Bojarski AJ, ... Popik P, et al. Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1H-Pyrrolo[3,2-c]quinolines with Neuroprotective and Pro-cognitive Activity. Acs Chemical Neuroscience. PMID 30896921 DOI: 10.1021/Acschemneuro.8B00618  0.422
2019 Malikowska-Racia N, Popik P, Sałat K. P.517 mGluR2/3 receptor antagonist LY341495 attenuates PTSD symptoms mimicked in a mouse model of single-prolonged stress European Neuropsychopharmacology. 29: S364-S365. DOI: 10.1016/j.euroneuro.2019.09.523  0.756
2019 Gołębiowska J, Nikiforuk A, Alenina N, Bader M, Popik P. Effects of genetic deficiency of tryptophan hydroxylase 2 on attentional processes in the five choice serial reaction time task in rats European Neuropsychopharmacology. 29: S506-S507. DOI: 10.1016/J.Euroneuro.2018.11.754  0.605
2019 Nikiforuk A, Potasiewicz A, Arias H, Popik P. Activation of the alpha4 beta2 nicotinic acetylcholine receptor facilitates set-shifting performance in rats European Neuropsychopharmacology. 29: S270-S271. DOI: 10.1016/J.Euroneuro.2018.11.429  0.798
2019 Holuj M, Potasiewicz A, Wojcik M, Nikiforuk A, Popik P. Effects of prenatal exposure to methylazoxymethanol acetate on juvenile social play behavior and ultrasonic communication in male and female rats European Neuropsychopharmacology. 29: S251-S252. DOI: 10.1016/J.Euroneuro.2018.11.399  0.788
2019 Krawczyk M, Hogendorf A, Hogendorf A, Matłoka M, Dubiel K, Moszczyński-Pętkowski R, Pieczykolan J, Bojarski A, Zajdel P, Popik P. Pro-cognitive effects of a AHN-208, 5-HT6 receptor antagonist, in the novel object recognition test in rats European Neuropsychopharmacology. 29: S148. DOI: 10.1016/J.Euroneuro.2018.11.264  0.457
2019 Potasiewicz A, Holuj M, Popik P, Agnieszka N. The effects of ligands of the alpha7 nicotinic acetylcholine receptors on memory and social behaviour in the neurodevelopmental model of schizophrenia European Neuropsychopharmacology. 29: S127. DOI: 10.1016/J.Euroneuro.2018.11.236  0.801
2018 Potasiewicz A, Golebiowska J, Popik P, Nikiforuk A. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors. Journal of Psychopharmacology (Oxford, England). 269881118812097. PMID 30501536 DOI: 10.1177/0269881118812097  0.814
2018 Potasiewicz A, Holuj M, Piotrowska D, Zajda K, Wojcik M, Popik P, Nikiforuk A. Evaluation of ultrasonic vocalizations in a neurodevelopmental model of schizophrenia during the early life stages of rats. Neuropharmacology. PMID 30448422 DOI: 10.1016/J.Neuropharm.2018.11.023  0.8
2018 Zajdel P, Kos T, Marciniec K, Satała G, Canale V, Kamiński K, Hołuj M, Lenda T, Koralewski R, Bednarski M, Nowiński L, Wójcikowski J, Daniel WA, Nikiforuk A, Nalepa I, ... ... Popik P, et al. Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects. European Journal of Medicinal Chemistry. 145: 790-804. PMID 29407591 DOI: 10.1016/J.Ejmech.2018.01.002  0.825
2017 Vanda D, Soural M, Canale V, Chaumont-Dubel S, Satała G, Kos T, Funk P, Fülöpová V, Lemrová B, Koczurkiewicz P, Pękala E, Bojarski AJ, Popik P, Marin P, Zajdel P. Novel non-sulfonamide 5-HT6 receptor partial inverse agonist in a group of imidazo[4,5-b]pyridines with cognition enhancing properties. European Journal of Medicinal Chemistry. 144: 716-729. PMID 29291439 DOI: 10.1016/J.Ejmech.2017.12.053  0.677
2017 Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J, Langer T, Höger H, Golebiowska J, Popik P, Lubec G. A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats. Frontiers in Behavioral Neuroscience. 11: 222. PMID 29230168 DOI: 10.3389/Fnbeh.2017.00222  0.683
2017 Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J, Langer T, Höger H, Golebiowska J, Popik P, Lubec G. A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats. Frontiers in Behavioral Neuroscience. 11: 222. PMID 29230168 DOI: 10.3389/fnbeh.2017.00222  0.327
2017 Nikiforuk A, Kalaba P, Ilic M, Korz V, Dragačević V, Wackerlig J, Langer T, Höger H, Golebiowska J, Popik P, Lubec G. A Novel Dopamine Transporter Inhibitor CE-123 Improves Cognitive Flexibility and Maintains Impulsivity in Healthy Male Rats. Frontiers in Behavioral Neuroscience. 11: 222. PMID 29230168 DOI: 10.3389/fnbeh.2017.00222  0.327
2017 Popik P, Hołuj M, Kos T, Nowak G, Librowski T, Sałat K. Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents. Neurotoxicity Research. PMID 28577066 DOI: 10.1007/S12640-017-9759-0  0.832
2017 Zurawek D, Salerno-Kochan A, Dziedzicka-Wasylewska M, Nikiforuk A, Kos T, Popik P. Changes in the expression of metabotropic glutamate receptor 5 (mGluR5) in a ketamine-based animal model of schizophrenia. Schizophrenia Research. PMID 28433499 DOI: 10.1016/J.Schres.2017.04.014  0.761
2017 Canale V, Partyka A, Kurczab R, Krawczyk M, Kos T, Satała G, Kubica B, Jastrzębska-Więsek M, Wesołowska A, Bojarski AJ, Popik P, Zajdel P. Novel 5-HT7R antagonists, arylsulfonamide derivatives of (aryloxy)propyl piperidines: Add-on effect to the antidepressant activity of SSRI and DRI, and pro-cognitive profile. Bioorganic & Medicinal Chemistry. PMID 28391970 DOI: 10.1016/J.Bmc.2017.03.057  0.648
2017 Potasiewicz A, Nikiforuk A, Hołuj M, Popik P. Stimulation of nicotinic acetylcholine alpha7 receptors rescue schizophrenia-like cognitive impairments in rats. Journal of Psychopharmacology (Oxford, England). 31: 260-271. PMID 28168926 DOI: 10.1177/0269881116675509  0.821
2016 Potasiewicz A, Hołuj M, Kos T, Popik P, Arias HR, Nikiforuk A. 3-Furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic receptor, reverses schizophrenia-like cognitive and social deficits in rats. Neuropharmacology. PMID 27717880 DOI: 10.1016/J.Neuropharm.2016.10.002  0.829
2016 Nikiforuk A, Potasiewicz A, Kos T, Popik P. The combination of memantine and galantamine improves cognition in rats: the synergistic role of the α7 nicotinic acetylcholine and NMDA receptors. Behavioural Brain Research. PMID 27435422 DOI: 10.1016/J.Bbr.2016.07.023  0.819
2016 Zajdel P, Marciniec K, Satała G, Canale V, Kos T, Partyka A, Jastrzębska-Więsek M, Wesołowska A, Basińska-Ziobroń A, Wójcikowski J, Daniel WA, Bojarski AJ, Popik P. N1-Azinylsulfonyl-1H-indoles: 5-HT6 Receptor Antagonists with Procognitive and Antidepressant-Like Properties. Acs Medicinal Chemistry Letters. 7: 618-622. PMID 27326337 DOI: 10.1021/Acsmedchemlett.6B00056  0.637
2016 Kregiel J, Golebiowska J, Popik P, Rygula R. Retraction notice to "Dopamine induces an optimism bias in rats-Pharmacological proof for the translational validity of the ambiguous-cue interpretation test" [Behav. Brain Res. 297 (2016) 84-90]. Behavioural Brain Research. 308: 245. PMID 27211202 DOI: 10.1016/J.Bbr.2016.09.046  0.675
2016 Grychowska K, Satała G, Kos T, Partyka A, Colacino E, Chaumont-Dubel S, Bantreil X, Wesołowska A, Pawlowski MH, Martinez J, Marin P, Subra G, Bojarski AJ, Lamaty F, Popik P, et al. Novel 1H-pyrrolo[3,2-c]quinoline based 5-HT6 receptor antagonists with potential application for the treatment of cognitive disorders associated with Alzheimer's disease. Acs Chemical Neuroscience. PMID 27100049 DOI: 10.1021/Acschemneuro.6B00090  0.673
2016 Rygula R, Popik P. Trait "pessimism" is associated with increased sensitivity to negative feedback in rats. Cognitive, Affective & Behavioral Neuroscience. PMID 26902303 DOI: 10.3758/S13415-016-0410-Y  0.713
2016 Nikiforuk A, Hołuj M, Kos T, Popik P. The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia. Neuropharmacology. PMID 26826431 DOI: 10.1016/J.Neuropharm.2016.01.035  0.843
2015 Canale V, Kurczab R, Partyka A, Satała G, Słoczyńska K, Kos T, Jastrzębska-Więsek M, Siwek A, Pękala E, Bojarski AJ, Wesołowska A, Popik P, Zajdel P. N-Alkylated arylsulfonamides of (aryloxy)ethyl piperidines: 5-HT7 receptor selectivity versus multireceptor profile. Bioorganic & Medicinal Chemistry. PMID 26706111 DOI: 10.1016/J.Bmc.2015.11.041  0.651
2015 Rafa D, Kregiel J, Popik P, Rygula R. Effects of optimism on gambling in the rat slot machine task. Behavioural Brain Research. 300: 97-105. PMID 26698397 DOI: 10.1016/J.Bbr.2015.12.013  0.793
2015 Nikiforuk A, Potasiewicz A, Rafa D, Drescher K, Bespalov A, Popik P. The effects of PDE10 inhibition on attentional set-shifting do not depend on the activation of dopamine D1 receptors. Behavioural Pharmacology. PMID 26580130 DOI: 10.1097/Fbp.0000000000000201  0.823
2015 Kregiel J, Golebiowska J, Popik P, Rygula R. Dopamine induces an optimism bias in rats-Pharmacological proof for the translational validity of the ambiguous-cue interpretation test. Behavioural Brain Research. 297: 84-90. PMID 26462571 DOI: 10.1016/J.Bbr.2015.10.020  0.72
2015 Kregiel J, Malek N, Popik P, Starowicz K, Rygula R. Anandamide mediates cognitive judgement bias in rats. Neuropharmacology. 101: 146-153. PMID 26363193 DOI: 10.1016/J.Neuropharm.2015.09.009  0.757
2015 Potasiewicz A, Kos T, Ravazzini F, Puia G, Arias HR, Popik P, Nikiforuk A. Pro-cognitive activity in rats of 3-furan-2-yl-N-p-tolyl-acrylamide, a positive allosteric modulator of the α7 nicotinic acetylcholine receptor. British Journal of Pharmacology. 172: 5123-35. PMID 26276349 DOI: 10.1111/Bph.13277  0.809
2015 Sałat K, Siwek A, Starowicz G, Librowski T, Nowak G, Drabik U, Gajdosz R, Popik P. Antidepressant-like effects of ketamine, norketamine and dehydronorketamine in forced swim test: Role of activity at NMDA receptor. Neuropharmacology. 99: 301-307. PMID 26240948 DOI: 10.1016/J.Neuropharm.2015.07.037  0.425
2015 Nikiforuk A, Kos T, Hołuj M, Potasiewicz A, Popik P. Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats. Neuropharmacology. 101: 389-400. PMID 26232639 DOI: 10.1016/J.Neuropharm.2015.07.034  0.827
2015 Popik P, Nikiforuk A. Attentional Set-Shifting Paradigm in the Rat. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. 72: 9.51.1-9.51.13. PMID 26131663 DOI: 10.1002/0471142301.Ns0951S72  0.646
2015 Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1300-13. PMID 26003081 DOI: 10.1016/J.Euroneuro.2015.04.018  0.829
2015 Nikiforuk A, Hołuj M, Potasiewicz A, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats. Behavioural Brain Research. 289: 149-56. PMID 25930219 DOI: 10.1016/J.Bbr.2015.04.030  0.834
2015 Skolnick P, Kos T, Czekaj J, Popik P. Effect of NMDAR antagonists in the tetrabenazine test for antidepressants: comparison with the tail suspension test. Acta Neuropsychiatrica. 27: 228-34. PMID 25858023 DOI: 10.1017/Neu.2015.14  0.721
2015 Ho?uj M, Popik P, Nikiforuk A. Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors. Behavioural Pharmacology. PMID 25769091 DOI: 10.1097/Fbp.0000000000000132  0.707
2015 Rygula R, Golebiowska J, Kregiel J, Kubik J, Popik P. Effects of optimism on motivation in rats. Frontiers in Behavioral Neuroscience. 9: 32. PMID 25762910 DOI: 10.3389/Fnbeh.2015.00032  0.704
2015 Rygula R, Golebiowska J, Kregiel J, Holuj M, Popik P. Acute administration of lithium, but not valproate, modulates cognitive judgment bias in rats. Psychopharmacology. 232: 2149-56. PMID 25537337 DOI: 10.1007/S00213-014-3847-0  0.82
2015 Popik P, Holuj M, Nikiforuk A, Kos T, Trullas R, Skolnick P. 1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats. Psychopharmacology. 232: 1025-38. PMID 25260339 DOI: 10.1007/S00213-014-3738-4  0.838
2015 Rygula R, Szczech E, Kregiel J, Golebiowska J, Kubik J, Popik P. Cognitive judgment bias in the psychostimulant-induced model of mania in rats. Psychopharmacology. 232: 651-60. PMID 25116482 DOI: 10.1007/S00213-014-3707-Y  0.722
2015 Zajdel P, Canale V, Partyka A, Marciniec K, Kurczab R, Satała G, Siwek A, Jastrzębska-Więsek M, Wesołowska A, Kos T, Popik P, Bojarski AJ. Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7 receptor antagonists and their psychotropic properties Medchemcomm. 6: 1272-1277. DOI: 10.1039/C5Md00166H  0.681
2015 Nikiforuk A, Kos T, Potasiewicz A, Popik P. Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats European Neuropsychopharmacology. 25: 1300-1313. DOI: 10.1016/j.euroneuro.2015.04.018  0.813
2015 Nikiforuk A, Hołuj M, Potasiewicz A, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 on premature responding in the five-choice serial reaction time test in rats Behavioural Brain Research. 289: 149-156. DOI: 10.1016/j.bbr.2015.04.030  0.81
2014 Rygula R, Szczech E, Papciak J, Nikiforuk A, Popik P. The effects of cocaine and mazindol on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. Behavioural Brain Research. 270: 206-12. PMID 24859175 DOI: 10.1016/J.Bbr.2014.05.026  0.773
2014 Nikiforuk A, Popik P. The effects of acute and repeated administration of ketamine on attentional performance in the five-choice serial reaction time task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1381-93. PMID 24846536 DOI: 10.1016/J.Euroneuro.2014.04.007  0.701
2014 Rygula R, Papciak J, Popik P. The effects of acute pharmacological stimulation of the 5-HT, NA and DA systems on the cognitive judgement bias of rats in the ambiguous-cue interpretation paradigm. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 24: 1103-11. PMID 24503278 DOI: 10.1016/J.Euroneuro.2014.01.012  0.727
2014 Nikiforuk A, Popik P. Ketamine prevents stress-induced cognitive inflexibility in rats. Psychoneuroendocrinology. 40: 119-22. PMID 24485483 DOI: 10.1016/J.Psyneuen.2013.11.009  0.686
2014 Popik P, Kos T, Pluta H, Nikiforuk A, Rojek K, RyguÅ‚a R. Inhibition of the glucocorticoid synthesis reverses stress-induced decrease in rat's 50-kHz ultrasonic vocalizations. Behavioural Brain Research. 260: 53-7. PMID 24308957 DOI: 10.1016/J.Bbr.2013.11.029  0.735
2014 FijaÅ‚ K, Popik P, Nikiforuk A. Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats. Psychopharmacology. 231: 269-81. PMID 23954911 DOI: 10.1007/S00213-013-3234-2  0.693
2013 Nikiforuk A, Popik P. Neurochemical modulation of stress-induced cognitive inflexibility in a rat model of an attentional set-shifting task. Pharmacological Reports : Pr. 65: 1479-88. PMID 24552995 DOI: 10.1016/S1734-1140(13)71508-1  0.628
2013 Papciak J, Popik P, Fuchs E, Rygula R. Chronic psychosocial stress makes rats more 'pessimistic' in the ambiguous-cue interpretation paradigm. Behavioural Brain Research. 256: 305-10. PMID 23993861 DOI: 10.1016/J.Bbr.2013.08.036  0.697
2013 Nikiforuk A, Kos T, FijaÅ‚ K, HoÅ‚uj M, Rafa D, Popik P. Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats. Plos One. 8: e66695. PMID 23776692 DOI: 10.1371/Journal.Pone.0066695  0.838
2013 Rygula R, Papciak J, Popik P. Trait pessimism predicts vulnerability to stress-induced anhedonia in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2188-96. PMID 23660704 DOI: 10.1038/Npp.2013.116  0.688
2013 Nikiforuk A, Popik P. Amisulpride promotes cognitive flexibility in rats: the role of 5-HT7 receptors. Behavioural Brain Research. 248: 136-40. PMID 23603557 DOI: 10.1016/J.Bbr.2013.04.008  0.704
2013 Nikiforuk A, FijaÅ‚ K, Potasiewicz A, Popik P, Kos T. The 5-hydroxytryptamine (serotonin) receptor 6 agonist EMD 386088 ameliorates ketamine-induced deficits in attentional set shifting and novel object recognition, but not in the prepulse inhibition in rats. Journal of Psychopharmacology (Oxford, England). 27: 469-76. PMID 23479455 DOI: 10.1177/0269881113480991  0.833
2013 Potasiewicz A, Nikiforuk A, Popik P. P.2.024 The effects of positive allosteric modulators of α7 nicotinic receptors on rats' performance in the odour span test European Neuropsychopharmacology. 23: S46. DOI: 10.1016/S0924-977X(13)70052-X  0.812
2013 Rafa D, Nikiforuk A, Popik P. P.2.023 The antagonist of 5-HT7 receptors, SB-269970, and amisulpride both reverse ketamine-induced cognitive inflexibility in rats European Neuropsychopharmacology. 23: S45. DOI: 10.1016/S0924-977X(13)70051-8  0.822
2012 Rygula R, Pluta H, Popik P. Laughing rats are optimistic. Plos One. 7: e51959. PMID 23300582 DOI: 10.1371/Journal.Pone.0051959  0.673
2012 Zelek-Molik A, Bielawski A, Kreiner G, Popik P, Vetulani J, Nalepa I. Morphine-induced place preference affects mRNA expression of G protein α subunits in rat brain. Pharmacological Reports : Pr. 64: 546-57. PMID 22814008 DOI: 10.1016/S1734-1140(12)70850-2  0.328
2012 Popik P, Potasiewicz A, Pluta H, Zieniewicz A. High-frequency ultrasonic vocalizations in rats in response to tickling: the effects of restraint stress. Behavioural Brain Research. 234: 223-7. PMID 22766213 DOI: 10.1016/J.Bbr.2012.06.028  0.716
2012 Nikiforuk A, Popik P. Effects of quetiapine and sertindole on subchronic ketamine-induced deficits in attentional set-shifting in rats. Psychopharmacology. 220: 65-74. PMID 21918808 DOI: 10.1007/S00213-011-2487-X  0.698
2011 Nikiforuk A, Kos T, Rafa D, Behl B, Bespalov A, Popik P. Blockade of glycine transporter 1 by SSR-504734 promotes cognitive flexibility in glycine/NMDA receptor-dependent manner. Neuropharmacology. 61: 262-7. PMID 21530555 DOI: 10.1016/J.Neuropharm.2011.04.010  0.825
2011 Fijal K, Popik P. Phencyclidine disturbs relational memory in the transitive inference task. Behavioural Pharmacology. 22: 262-5. PMID 21522055 DOI: 10.1097/Fbp.0B013E328345C842  0.44
2011 Łopuch S, Popik P. Cooperative behavior of laboratory rats (Rattus norvegicus) in an instrumental task. Journal of Comparative Psychology (Washington, D.C. : 1983). 125: 250-3. PMID 21341907 DOI: 10.1037/A0021532  0.379
2011 Kos T, Nikiforuk A, Rafa D, Popik P. The effects of NMDA receptor antagonists on attentional set-shifting task performance in mice. Psychopharmacology. 214: 911-21. PMID 21161188 DOI: 10.1007/S00213-010-2102-6  0.824
2011 Nikiforuk A, Popik P. Long-lasting cognitive deficit induced by stress is alleviated by acute administration of antidepressants. Psychoneuroendocrinology. 36: 28-39. PMID 20580164 DOI: 10.1016/J.Psyneuen.2010.06.001  0.669
2011 Popik P, Kos T, Zhang Y, Bisaga A. Memantine reduces consumption of highly palatable food in a rat model of binge eating. Amino Acids. 40: 477-85. PMID 20571841 DOI: 10.1007/S00726-010-0659-3  0.614
2011 Nikiforuk A, Popik P. P.1.g.006 A selective blockade of 5-HT7 receptors promotes cognitive flexibility in rats European Neuropsychopharmacology. 21: S332. DOI: 10.1016/S0924-977X(11)70527-2  0.634
2010 Nikiforuk A, Popik P, Drescher KU, van Gaalen M, Relo AL, Mezler M, Marek G, Schoemaker H, Gross G, Bespalov A. Effects of a positive allosteric modulator of group II metabotropic glutamate receptors, LY487379, on cognitive flexibility and impulsive-like responding in rats. The Journal of Pharmacology and Experimental Therapeutics. 335: 665-73. PMID 20739457 DOI: 10.1124/Jpet.110.170506  0.703
2010 Popik P, Kamysz E, Kreczko J, Wróbel M. Human opiorphin: the lack of physiological dependence, tolerance to antinociceptive effects and abuse liability in laboratory mice. Behavioural Brain Research. 213: 88-93. PMID 20438769 DOI: 10.1016/J.Bbr.2010.04.045  0.36
2010 Nikiforuk A, GoÅ‚embiowska K, Popik P. Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 20: 37-48. PMID 19729284 DOI: 10.1016/J.Euroneuro.2009.08.001  0.71
2010 Skolnick P, Popik P, Trullas R. N-methyl-D-aspartate (NMDA) antagonists for the treatment of depression Milestones in Drug Therapy. 1-20. DOI: 10.1007/978-3-0346-0241-9_1  0.658
2009 Skolnick P, Popik P, Trullas R. Glutamate-based antidepressants: 20 years on. Trends in Pharmacological Sciences. 30: 563-9. PMID 19837463 DOI: 10.1016/J.Tips.2009.09.002  0.703
2009 Siwek M, Dudek D, Paul IA, Sowa-Kućma M, Zieba A, Popik P, Pilc A, Nowak G. Zinc supplementation augments efficacy of imipramine in treatment resistant patients: a double blind, placebo-controlled study. Journal of Affective Disorders. 118: 187-95. PMID 19278731 DOI: 10.1016/J.Jad.2009.02.014  0.591
2009 Schneider T, Popik P. An animal model of premenstrual dysphoric disorder sensitive to antidepressants. Current Protocols in Neuroscience / Editorial Board, Jacqueline N. Crawley ... [Et Al.]. Unit 9.31. PMID 19170024 DOI: 10.1002/0471142301.Ns0931S46  0.33
2009 Nikiforuk A, Popik P. Antidepressants alleviate the impact of reinforcer downshift. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 19: 41-8. PMID 18805678 DOI: 10.1016/J.Euroneuro.2008.08.002  0.641
2008 Popik P, Kos T, Sowa-Kućma M, Nowak G. Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology. 198: 421-30. PMID 18458881 DOI: 10.1007/S00213-008-1158-Z  0.661
2008 Bisaga A, Kos T, Wójcikowski J, Daniel WA, Popik P. Brain levels of dextromethorphan and the intensity of opioid withdrawal in mice. Drug and Alcohol Dependence. 95: 147-51. PMID 18328640 DOI: 10.1016/J.Drugalcdep.2008.01.007  0.591
2008 Nikiforuk A, Popik P. P.1.d.002 The effect of chlordiazepoxide on reward reduction-induced decrease of operant performance European Neuropsychopharmacology. 18: S249-S250. DOI: 10.1016/S0924-977X(08)70317-1  0.545
2007 Schneider T, Popik P. Attenuation of estrous cycle-dependent marble burying in female rats by acute treatment with progesterone and antidepressants. Psychoneuroendocrinology. 32: 651-9. PMID 17561352 DOI: 10.1016/J.Psyneuen.2007.04.003  0.348
2007 Basile AS, Janowsky A, Golembiowska K, Kowalska M, Tam E, Benveniste M, Popik P, Nikiforuk A, Krawczyk M, Nowak G, Krieter PA, Lippa AS, Skolnick P, Koustova E. Characterization of the antinociceptive actions of bicifadine in models of acute, persistent, and chronic pain. The Journal of Pharmacology and Experimental Therapeutics. 321: 1208-25. PMID 17325229 DOI: 10.1124/Jpet.106.116483  0.747
2007 Kozela E, Popik P. A complete analysis of NMDA receptor subunits in periaqueductal grey and ventromedial medulla of morphine tolerant mice. Drug and Alcohol Dependence. 86: 290-3. PMID 16930867 DOI: 10.1016/J.Drugalcdep.2006.06.018  0.736
2007 Belozertseva IV, Kos T, Popik P, Danysz W, Bespalov AY. Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 17: 172-9. PMID 16630709 DOI: 10.1016/J.Euroneuro.2006.03.002  0.674
2006 Popik P, Kostakis E, Krawczyk M, Nowak G, Szewczyk B, Krieter P, Chen Z, Russek SJ, Gibbs TT, Farb DH, Skolnick P, Lippa AS, Basile AS. The anxioselective agent 7-(2-chloropyridin-4-yl)pyrazolo-[1,5-a]-pyrimidin-3-yl](pyridin-2-yl)methanone (DOV 51892) is more efficacious than diazepam at enhancing GABA-gated currents at alpha1 subunit-containing GABAA receptors. The Journal of Pharmacology and Experimental Therapeutics. 319: 1244-52. PMID 16971504 DOI: 10.1124/Jpet.106.107201  0.653
2006 Skolnick P, Krieter P, Tizzano J, Basile A, Popik P, Czobor P, Lippa A. Preclinical and clinical pharmacology of DOV 216,303, a "triple" reuptake inhibitor. Cns Drug Reviews. 12: 123-34. PMID 16958986 DOI: 10.1111/J.1527-3458.2006.00123.X  0.684
2006 Kos T, Legutko B, Danysz W, Samoriski G, Popik P. Enhancement of antidepressant-like effects but not brain-derived neurotrophic factor mRNA expression by the novel N-methyl-D-aspartate receptor antagonist neramexane in mice. The Journal of Pharmacology and Experimental Therapeutics. 318: 1128-36. PMID 16740621 DOI: 10.1124/Jpet.106.103697  0.657
2006 Popik P, Krawczyk M, Golembiowska K, Nowak G, Janowsky A, Skolnick P, Lippa A, Basile AS. Pharmacological profile of the "triple" monoamine neurotransmitter uptake inhibitor, DOV 102,677. Cellular and Molecular Neurobiology. 26: 857-73. PMID 16636898 DOI: 10.1007/S10571-006-9012-5  0.7
2006 Kos T, Popik P, Pietraszek M, Schäfer D, Danysz W, Dravolina O, Blokhina E, Galankin T, Bespalov AY. Effect of 5-HT3 receptor antagonist MDL 72222 on behaviors induced by ketamine in rats and mice. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 16: 297-310. PMID 16288851 DOI: 10.1016/J.Euroneuro.2005.10.001  0.686
2006 Popik P, Wrobel M, Bisaga A. Reinstatement of morphine-conditioned reward is blocked by memantine. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 160-70. PMID 15886718 DOI: 10.1038/Sj.Npp.1300760  0.382
2005 Kozela E, Wrobel M, Kos T, Wojcikowski J, Daniel WA, Wozniak KM, Slusher BS, Popik P. 2-MPPA, a selective glutamate carboxypeptidase II inhibitor, attenuates morphine tolerance but not dependence in C57/Bl mice. Psychopharmacology. 183: 275-84. PMID 16220328 DOI: 10.1007/S00213-005-0182-5  0.777
2005 Popik P, Krawczyk M, Kos T, Nalepa I, Kowalska M, Witarski T, Antkiewicz-Michaluk L, Vetulani J. Nicotine produces antidepressant-like actions: Behavioral and neurochemical evidence. European Journal of Pharmacology. 515: 128-33. PMID 15893747 DOI: 10.1016/J.Ejphar.2005.04.009  0.638
2005 Kos T, Popik P. A comparison of the predictive therapeutic and undesired side-effects of the NMDA receptor antagonist, memantine, in mice. Behavioural Pharmacology. 16: 155-61. PMID 15864070 DOI: 10.1097/00008877-200505000-00004  0.612
2005 Danysz W, Kozela E, Parsons CG, Sladek M, Bauer T, Popik P. Peripherally acting NMDA receptor/glycineB site receptor antagonists inhibit morphine tolerance. Neuropharmacology. 48: 360-71. PMID 15721168 DOI: 10.1016/J.Neuropharm.2004.11.005  0.756
2005 Popik P, Kos T, Pietraszek M, fer DS, Danysz W, Dravolina O, Blokhina E, Galankin T, Bespalov AY. B75 Effect Of 5-Ht3 Receptor Antagonist Mdl 72222 On Behaviors Induced By Ketamine In Rats And Mice Behavioural Pharmacology. 16. DOI: 10.1097/00008877-200509001-00280  0.654
2003 Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS. "Broad spectrum" antidepressants: is more better for the treatment of depression? Life Sciences. 73: 3175-9. PMID 14561522 DOI: 10.1016/J.Lfs.2003.06.007  0.507
2003 Popik P, Kozela E, Krawczyk M. Nicotine and nicotinic receptor antagonists potentiate the antidepressant-like effects of imipramine and citalopram. British Journal of Pharmacology. 139: 1196-202. PMID 12871839 DOI: 10.1038/Sj.Bjp.0705359  0.752
2003 Popik P, Wrobel M, Rygula R, Bisaga A, Bespalov AY. Effects of memantine, an NMDA receptor antagonist, on place preference conditioned with drug and nondrug reinforcers in mice. Behavioural Pharmacology. 14: 237-44. PMID 12799526 DOI: 10.1097/00008877-200305000-00008  0.707
2003 Popik P, Kozela E, Wróbel M, Wozniak KM, Slusher BS. Morphine tolerance and reward but not expression of morphine dependence are inhibited by the selective glutamate carboxypeptidase II (GCP II, NAALADase) inhibitor, 2-PMPA. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 457-67. PMID 12629525 DOI: 10.1038/Sj.Npp.1300048  0.732
2003 Skolnick P, Popik P, Janowsky A, Beer B, Lippa AS. Antidepressant-like actions of DOV 21,947: a "triple" reuptake inhibitor. European Journal of Pharmacology. 461: 99-104. PMID 12586204 DOI: 10.1016/S0014-2999(03)01310-4  0.532
2003 Kozela E, Pilc A, Popik P. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Psychopharmacology. 165: 245-51. PMID 12442203 DOI: 10.1007/S00213-002-1287-8  0.758
2002 Popik P, Wróbel M. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Neuropharmacology. 43: 1210-7. PMID 12527470 DOI: 10.1016/S0028-3908(02)00309-X  0.375
2002 Kozela E, Popik P. The effects of NMDA receptor antagonists on acute morphine antinociception in mice. Amino Acids. 23: 163-8. PMID 12373532 DOI: 10.1007/S00726-001-0123-5  0.747
2001 Popik P, Wróbel M. Anxiogenic action of ibogaine. The Alkaloids. Chemistry and Biology. 56: 227-33. PMID 11705110 DOI: 10.1016/S0099-9598(01)56016-2  0.314
2001 Bisaga A, Comer SD, Ward AS, Popik P, Kleber HD, Fischman MW. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans. Psychopharmacology. 157: 1-10. PMID 11512037 DOI: 10.1007/S002130100739  0.346
2001 Kozela E, Danysz W, Popik P. Uncompetitive NMDA receptor antagonists potentiate morphine antinociception recorded from the tail but not from the hind paw in rats. European Journal of Pharmacology. 423: 17-26. PMID 11438302 DOI: 10.1016/S0014-2999(01)01084-6  0.765
2001 Popik P, Galoch Z, Janusz M, Lisowski J, Vetulani J. Cognitive effects of Colostral-Val nonapeptide in aged rats. Behavioural Brain Research. 118: 201-8. PMID 11164518 DOI: 10.1016/S0166-4328(00)00323-5  0.354
2001 Kozela E, Popik P, Danysz W. Dextromethorphan, memantine and MRZ 2/579, low affinity NMDA receptor antagonists, potentiate morphine antinociception recorded from the tail but not from the paw Pharmacological Reports. 53: 179-180.  0.726
2000 Bisaga A, Popik P, Bespalov AY, Danysz W. Therapeutic potential of NMDA receptor antagonists in the treatment of alcohol and substance use disorders. Expert Opinion On Investigational Drugs. 9: 2233-48. PMID 11060803 DOI: 10.1517/13543784.9.10.2233  0.344
2000 Popik P, Wróbel M, Nowak G. Chronic treatment with antidepressants affects glycine/NMDA receptor function: behavioral evidence. Neuropharmacology. 39: 2278-87. PMID 10974311 DOI: 10.1016/S0028-3908(00)00090-3  0.415
2000 Popik P, Kozela E, Pilc A. Selective agonist of group II glutamate metabotropic receptors, LY354740, inhibits tolerance to analgesic effects of morphine in mice. British Journal of Pharmacology. 130: 1425-31. PMID 10903986 DOI: 10.1038/Sj.Bjp.0703438  0.755
2000 Popik P, Kozela E, Danysz W. Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice. Naunyn-Schmiedeberg's Archives of Pharmacology. 361: 425-32. PMID 10763858 DOI: 10.1007/S002109900205  0.75
2000 Bisaga A, Popik P. In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. Drug and Alcohol Dependence. 59: 1-15. PMID 10706971 DOI: 10.1016/S0376-8716(99)00107-6  0.375
1999 KÅ‚odziÅ„ska A, Chojnacka-Wójcik E, PaÅ‚ucha A, BraÅ„ski P, Popik P, Pilc A. Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models. Neuropharmacology. 38: 1831-9. PMID 10608278 DOI: 10.1016/S0028-3908(99)00066-0  0.435
1999 Popik P, Kozela E. Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test. Polish Journal of Pharmacology. 51: 223-31. PMID 10600036  0.736
1999 Popik P. Preclinical pharmacology of citalopram. Journal of Clinical Psychopharmacology. 19: 4S-22S. PMID 10507505 DOI: 10.1097/00004714-199910001-00002  0.335
1999 Popik P, Bobula B, Janusz M, Lisowski J, Vetulani J. Colostrinin, a polypeptide isolated from early milk, facilitates learning and memory in rats. Pharmacology, Biochemistry, and Behavior. 64: 183-9. PMID 10495015 DOI: 10.1016/S0091-3057(99)00101-X  0.362
1999 Popik P, Kolasiewicz W. Mesolimbic NMDA receptors are implicated in the expression of conditioned morphine reward. Naunyn-Schmiedeberg's Archives of Pharmacology. 359: 288-94. PMID 10344527 DOI: 10.1007/Pl00005354  0.423
1998 Popik P, van Ree JM. Neurohypophyseal peptides and social recognition in rats. Progress in Brain Research. 119: 415-36. PMID 10074804 DOI: 10.1016/S0079-6123(08)61585-X  0.57
1998 Danysz W, Parsons CG, Karcz-Kubicha M, Schwaier A, Popik P, Wedzony K, Lazarewicz J, Quack G. GlycineB antagonists as potential therapeutic agents. Previous hopes and present reality. Amino Acids. 14: 235-9. PMID 9871467 DOI: 10.1007/Bf01345268  0.419
1998 Popik P, Mamczarz J, Fraczek M, WidÅ‚a M, Hesselink M, Danysz W. Inhibition of reinforcing effects of morphine and naloxone-precipitated opioid withdrawal by novel glycine site and uncompetitive NMDA receptor antagonists. Neuropharmacology. 37: 1033-42. PMID 9833632 DOI: 10.1016/S0028-3908(98)00105-1  0.426
1998 Nowak G, Legutko B, Skolnick P, Popik P. Adaptation of cortical NMDA receptors by chronic treatment with specific serotonin reuptake inhibitors. European Journal of Pharmacology. 342: 367-70. PMID 9548410 DOI: 10.1016/S0014-2999(97)01589-6  0.53
1998 Lewin AH, Sun G, Fudala L, Navarro H, Zhou LM, Popik P, Faynsteyn A, Skolnick P. Molecular features associated with polyamine modulation of NMDA receptors. Journal of Medicinal Chemistry. 41: 988-95. PMID 9526573 DOI: 10.1021/Jm9707129  0.497
1998 Popik P, Skolnick P. Chapter 3 Pharmacology of Ibogaine And Ibogaine-Related Alkaloids Alkaloids: Chemistry and Biology. 52: 197-231. DOI: 10.1016/S0099-9598(08)60027-9  0.434
1996 Popik P. Facilitation of memory retrieval by the "anti-addictive" alkaloid, ibogaine. Life Sciences. 59: PL379-85. PMID 8950313 DOI: 10.1016/S0024-3205(96)00564-4  0.361
1996 Layer RT, Skolnick P, Bertha CM, Bandarage UK, Kuehne ME, Popik P. Structurally modified ibogaine analogs exhibit differing affinities for NMDA receptors. European Journal of Pharmacology. 309: 159-65. PMID 8874134 DOI: 10.1016/0014-2999(96)00304-4  0.755
1996 Skolnick P, Layer RT, Popik P, Nowak G, Paul IA, Trullas R. Adaptation of N-methyl-D-aspartate (NMDA) receptors following antidepressant treatment: implications for the pharmacotherapy of depression. Pharmacopsychiatry. 29: 23-6. PMID 8852530 DOI: 10.1055/S-2007-979537  0.807
1996 Popik P, Vetulani J, Van Ree JM. Facilitation and attenuation of social recognition in rats by different oxytocin-related peptides. European Journal of Pharmacology. 308: 113-6. PMID 8840121 DOI: 10.1016/0014-2999(96)00215-4  0.556
1996 Popik P, Skolnick P. The NMDA antagonist memantine blocks the expression and maintenance of morphine dependence. Pharmacology, Biochemistry, and Behavior. 53: 791-7. PMID 8801580 DOI: 10.1016/0091-3057(95)02163-9  0.551
1996 Pilc A, Popik P, Tatarczyńska E, Wójcik E. The antagonists of metabotropic glutamate receptors produce anxiolytic-like effects and attenuate morphine abstinence symptoms in animals Neuropharmacology. 35: A23. DOI: 10.1016/0028-3908(96)84736-8  0.401
1995 Popik P, Lewin A, Berrang B, Nowak G, Layer R, Skolnick P. [3H]1-aminocyclopropanecarboxylic acid, a novel probe for strychnine- insensitive glycine receptors. European Journal of Pharmacology. 291: 221-7. PMID 8719405 DOI: 10.1016/0922-4106(95)90061-6  0.74
1995 Layer RT, Popik P, Olds T, Skolnick P. Antidepressant-like actions of the polyamine site NMDA antagonist, eliprodil (SL-82.0715). Pharmacology, Biochemistry, and Behavior. 52: 621-7. PMID 8545484 DOI: 10.1016/0091-3057(95)00155-P  0.787
1995 Popik P, Layer RT, Skolnick P. 100 years of ibogaine: neurochemical and pharmacological actions of a putative anti-addictive drug. Pharmacological Reviews. 47: 235-53. PMID 7568327  0.707
1995 Popik P, Layer RT, Fossom LH, Benveniste M, Geter-Douglass B, Witkin JM, Skolnick P. NMDA antagonist properties of the putative antiaddictive drug, ibogaine. The Journal of Pharmacology and Experimental Therapeutics. 275: 753-60. PMID 7473163  0.776
1994 Paul IA, Nowak G, Layer RT, Popik P, Skolnick P. Adaptation of the N-methyl-D-aspartate receptor complex following chronic antidepressant treatments. The Journal of Pharmacology and Experimental Therapeutics. 269: 95-102. PMID 8169857  0.803
1994 Popik P, Nalepa I, Mamczarz J, Vetulani J. Retrieval associated cholinergic activity and its inhibition by memory updating. Life Sciences. 54: 1251-7. PMID 8164507 DOI: 10.1016/0024-3205(94)00852-3  0.349
1994 Popik P, Mamczarz J, Vetulani J. The effect of electroconvulsive shock and nifedipine on spatial learning and memory in rats. Biological Psychiatry. 35: 864-9. PMID 8054409 DOI: 10.1016/0006-3223(94)90022-1  0.31
1994 Popik P, Layer RT, Skolnick P. The putative anti-addictive drug ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor complex. Psychopharmacology. 114: 672-4. PMID 7531855 DOI: 10.1007/Bf02245000  0.765
1994 Lewin AH, Lamb PB, Popik P, Skolnick P. One-step preparation of [2,3-3H]-aminocyclo- propanecarboxylic acid: A useful ligand for strychnine-insensitive glycine receptors Journal of Labelled Compounds and Radiopharmaceuticals. 34: 1063-1068. DOI: 10.1002/Jlcr.2580341109  0.498
1993 Popik P, Van Ree JM. Social transmission of flavored tea preferences: facilitation by a vasopressin analog and oxytocin. Behavioral and Neural Biology. 59: 63-8. PMID 8442734 DOI: 10.1016/0163-1047(93)91173-K  0.57
1993 Nowak G, Paul IA, Popik P, Young A, Skolnick P. Ca2+ antagonists effect an antidepressant-like adaptation of the NMDA receptor complex. European Journal of Pharmacology. 247: 101-2. PMID 8258355 DOI: 10.1016/0922-4106(93)90144-X  0.696
1993 Popik P, Vetulani J, van Ree JM. Social memory and neurohypophyseal hormones European Neuropsychopharmacology. 3: 200-201. DOI: 10.1016/0924-977X(93)90024-G  0.548
1992 Popik P, Vos PE, Van Ree JM. Neurohypophyseal hormone receptors in the septum are implicated in social recognition in the rat. Behavioural Pharmacology. 3: 351-358. PMID 11224137 DOI: 10.1097/00008877-199208000-00011  0.616
1992 Popik P, Vetulani J, van Ree JM. Low doses of oxytocin facilitate social recognition in rats. Psychopharmacology. 106: 71-4. PMID 1738795 DOI: 10.1007/Bf02253591  0.558
1992 Popik P, Van Ree JM. Long-term facilitation of social recognition in rats by vasopressin related peptides: a structure-activity study. Life Sciences. 50: 567-72. PMID 1736027 DOI: 10.1016/0024-3205(92)90368-Y  0.562
1991 Popik P, Wolterink G, De Brabander H, van Ree JM. Neuropeptides related to [Arg8]vasopressin facilitates social recognition in rats. Physiology & Behavior. 49: 1031-5. PMID 1896485 DOI: 10.1016/0031-9384(91)90327-K  0.581
1991 Popik P, Vetulani J, Bisaga A, van Ree JM. Recognition cue in the rat's social memory paradigm. Journal of Basic and Clinical Physiology and Pharmacology. 2: 315-27. PMID 1822146 DOI: 10.1515/Jbcpp.1991.2.4.315  0.574
1991 Popik P, van Ree JM. Oxytocin but not vasopressin facilitates social recognition following injection into the medial preoptic area of the rat brain. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 1: 555-60. PMID 1668316 DOI: 10.1016/0924-977X(91)90010-R  0.592
Show low-probability matches.